AMY DAVIDSON: Open Payments
NPI 1194393991 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 21 payments from 10 companies in 2025. Trend: 2023 $164 · 2024 $413 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $191 |
| Penumbra, Inc. | 1 | $152 |
| Kestra Medical Technology Services, Inc. | 1 | $93 |
| PFIZER INC. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, Penumbra System, Assure WCD, VYNDAQEL, JARDIANCE, UPTRAVI, REPATHA, CAMZYOS.
Industry payments across KY — which companies pay providers there.
